Sun Pharmaceutical Industries on Monday said it is acquiring an 18.75 per cent stake in Israel-based Tarsius Pharma for a cash consideration of $3 million (over Rs 21 crore).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
